The effect of indomethacin on plasma renin activity and urinary aldosterone of patients with essential hypertension
- PMID: 756881
- DOI: 10.1007/BF03350976
The effect of indomethacin on plasma renin activity and urinary aldosterone of patients with essential hypertension
Abstract
The effect of indomethacin on plasma renin activity (PRA), urinary aldosterone, 17 OH ketogenic steroids and plasma cortisol was studied in twenty-three patients with essential hypertension and compared in eleven patients to oxprenolol effect by 2 x 2 factorial trial. Indomethacin decreased PRA and urinary aldosterone: its effect was maintained when the drug was given for three days and it was related to basal PRA and aldosterone values. Therefore in patients with low PRA (renin-sodium index) PRA and aldosterone were unchanged, while they decreased in the normal high PRA group. Aldosterone changes were related to those of PRA, while 17 OH ketogenic steroids and plasma cortisol were unchanged. Both indomethacin and oxprenolol decreased PRA, but no interaction or additive effect was found between the two drugs. The present data indicate that indomethacin can decrease both PRA and aldosterone to an extent which is related to basal values and that aldosterone changes are mainly explained by those of PRA. The PRA unresponsiveness to indomethacin found in low renin patients may suggest renal prostaglandin deficiency. Finally the lack of interaction or of additive effect between indomethacin and oxprenolol may be explained by postulating either that the two drugs act on a common pathway or that an additive effect on PRA cannot be detected renin being maximally suppressed by full renal beta-receptors blockade.
Similar articles
-
Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients.Eur J Clin Pharmacol. 1982;22(3):197-201. doi: 10.1007/BF00545214. Eur J Clin Pharmacol. 1982. PMID: 7049707 Clinical Trial.
-
The effect of oxprenolol and indomethacin on renin and aldosterone of normal subjects during low sodium diet.Eur J Clin Invest. 1982 Apr;12(2):107-11. doi: 10.1111/j.1365-2362.1982.tb00946.x. Eur J Clin Invest. 1982. PMID: 6807681 Clinical Trial.
-
The effect of clonidine on renin and aldosterone of hypertensive patients.Int J Clin Pharmacol Ther Toxicol. 1980;18(2):50-6. Int J Clin Pharmacol Ther Toxicol. 1980. PMID: 6989768
-
The renin-angiotensin-aldosterone system and blood pressure during oxprenolol treatment in hypertensive patients pretreated with diuretics.Int J Clin Pharmacol Ther Toxicol. 1982 Nov;20(11):538-42. Int J Clin Pharmacol Ther Toxicol. 1982. PMID: 6757151
-
Low-renin hypertension of childhood.Pediatr Nephrol. 1987 Jan;1(1):99-108. doi: 10.1007/BF00866890. Pediatr Nephrol. 1987. PMID: 3153266 Review.
Cited by
-
Do nonsteroidal anti-inflammatory drugs interfere with blood pressure control in hypertensive patients?J Gen Intern Med. 1987 Mar-Apr;2(2):108-12. doi: 10.1007/BF02596307. J Gen Intern Med. 1987. PMID: 3550008 Review.
-
Treatment of central serous chorioretinopathy with topical NSAIDs.Clin Ophthalmol. 2019 Aug 15;13:1543-1548. doi: 10.2147/OPTH.S202047. eCollection 2019. Clin Ophthalmol. 2019. PMID: 31616132 Free PMC article.
-
Neuroendocrine response to diclofenac in healthy subjects: a pilot study.J Endocrinol Invest. 2023 Dec;46(12):2617-2627. doi: 10.1007/s40618-023-02118-z. Epub 2023 May 27. J Endocrinol Invest. 2023. PMID: 37243865 Free PMC article.
-
The involvement of arachidonic acid metabolism in the control of renin release.J Endocrinol Invest. 1980 Apr-Jun;3(2):193-201. doi: 10.1007/BF03348251. J Endocrinol Invest. 1980. PMID: 6993550 Review. No abstract available.
-
Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients.Eur J Clin Pharmacol. 1982;22(3):197-201. doi: 10.1007/BF00545214. Eur J Clin Pharmacol. 1982. PMID: 7049707 Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials